Califf Clears First Senate Hurdle, But FDA Abortion Pill Decision May Complicate Final Confirmation

Republican opposition to Califf over the agency’s recent move to relax its Mifeprex restrictions is ominous since in order be confirmed as FDA commissioner he’ll need enough GOP votes to make up for Democratic opposition over his opioid track record and connections to the drug industry.

Robert Califf testisified 14 Dec 2022 at the Senate HELP committee
Robert Califf testified on 14 December at the Senate HELP Committee • Source: Alamy

More from US FDA

More from Agency Leadership